• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Identification and analysis of novel regulatory mechanisms of hepatic glucose and lipid metabolism

Research Project

Project/Area Number 17390264
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Metabolomics
Research InstitutionKobe University

Principal Investigator

OGAWA Wataru  Kobe University, Graduate School of Medicine, Associate Professor, 医学系研究科, 助教授 (40294219)

Project Period (FY) 2005 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥15,000,000 (Direct Cost: ¥15,000,000)
Fiscal Year 2006: ¥5,900,000 (Direct Cost: ¥5,900,000)
Fiscal Year 2005: ¥9,100,000 (Direct Cost: ¥9,100,000)
KeywordsSTAT3 / Insulin action / CNS metabolic regulation / gluconeogenesis / glucokinase / glucose action / インスリン / 糖尿病 / 転写因子 / 肝臓
Research Abstract

STAT3 regulates glucose homeostasis by suppressing the expression of gluconeogenic genes in the liver. The mechanism by which hepatic STAT3 is regulated by nutritional or hormonal status has remained unknown, however. Here, we show that an increase in the plasma insulin concentration, achieved either by glucose administration or by intravenous insulin infusion, stimulates tyrosine phosphorylation of STAT3 in the liver. This effect of insulin was mediated by the hormone' s effects in the brain, and the increase in hepatic IL-6 induced by the brain-insulin action is essential for the activation of STAT3. The inhibition of hepatic glucose production and of expression of gluconeogenic genes induced by intracerebral ventricular insulin infusion was impaired in mice with liver-specific STAT3 deficiency or in mice with IL-6 deficiency. These results thus indicate that IL-6-STAT3 signaling in the liver contributes to insulin action in the brain, leading to the suppression of hepatic glucose pr … More oduction.
Phosphoinositide-dependent kinase-1 (PDK1) is implicated in the metabolic effects of insulin as a key mediator of phosphoinositide 3-kinase-dependent signaling. Here we show that mice with liver-specific PDK1 deficiency manifest various defects in the metabolic actions of insulin in the liver as well as a type 2 diabetes-like phenotype characterized by marked hyperinsulinemia and postprandial hyperglycemia. The hepatic abundance of glucokinase, an important determinant of glucose flux and glucose-evoked signaling in hepatocytes, was substantially reduced in these mice. Restoration of hepatic glucokinase expression, with the use of an adenoviral vector, induced insulin-like effects in the liver and almost completely normalized the fasting hyperinsulinemia and postprandial hyperglycemia in these animals. These results indicate that, if the hepatic abundance of glucokinase is maintained, ingested glucose is normally disposed of even in the absence of acute activation of proximal insulin signaling, such as the activation of Akt, in the liver. Less

Report

(3 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • Research Products

    (10 results)

All 2007 2006 2005

All Journal Article (10 results)

  • [Journal Article] Restoration of glucokinase expression in the liver normalizes postprandial glucose disposal in mice with hepatic deficiency of PDK12007

    • Author(s)
      Okamoto Y 他
    • Journal Title

      Diabetes 56・4

      Pages: 1000-1009

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass.2007

    • Author(s)
      Hashimoto N et al.
    • Journal Title

      Nat Genet 38-5

      Pages: 589-593

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Restoration of glucokinase expression in the liver normalizes postprandial glucose disposal in mice with hepatic deficiency of PDK12007

    • Author(s)
      Okamoto Y 他
    • Journal Title

      Diabetes (in press)

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass2006

    • Author(s)
      Hashimoto N他
    • Journal Title

      Nat Genet 38・5

      Pages: 589-593

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.2006

    • Author(s)
      Inoue H 他
    • Journal Title

      Cell Metab. 3・4

      Pages: 267-275

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Annual Research Report 2006 Final Research Report Summary
  • [Journal Article] Restoration of glucokinase expression in the liver normalizes postprandial glucose disposal in mice with hepatic deficiency of PDK12006

    • Author(s)
      Okamoto Y et al.
    • Journal Title

      Diabetes 56-4

      Pages: 1000-1009

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.2006

    • Author(s)
      Inoue H et al.
    • Journal Title

      Cell Metab 3-4

      Pages: 267-275

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass2006

    • Author(s)
      Hashimoto N 他
    • Journal Title

      Nat Genet 38・5

      Pages: 589-593

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice.2005

    • Author(s)
      Haga S
    • Journal Title

      J Hepatol. 43・5

      Pages: 799-807

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Role of Kruppel-like factor 15 in PEPCK gene expression in the liver.2005

    • Author(s)
      Teshigawara K
    • Journal Title

      Biochem Biophys Res Commun. 327・3

      Pages: 920-926

    • Related Report
      2005 Annual Research Report

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi